Stocktoria

Amplifon S.p.A. AMP.MI

IT · Borsa Italiana · XMIL · stock · Healthcare · website

Amplifon S.p.A. (AMP.MI) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 2.44% (safety: stretched). FY2025 revenue was €2.4B at a 3.8% net margin.

Chart by TradingView
5/9
Piotroski F — financial health
0.79
Altman Z″ — distress risk · distress
1.1%
Dividend yield 5y avg · stretched · Dividend payout 71.5%

Quality score trend · recomputed for each fiscal year

Piotroski F /9
7 6 5 202320242025
Altman Z″
0.76 0.98 0.79 202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

€10.08 as of 2026-07-01 · -31.7% 1y
€9.40€15.5652-wk
Market cap USD$3.1B
P / E29.3×
Dividend yield 5y avg1.1%
Net margin 5y avg6.3%
Return on equity 5y avg13.2%
Beta0.94
Employees11,792

Analyst price target

€12.84 +27.4% vs last
consensus: hold · 16 analysts
target range €9.85 – €17.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Revenue trend · last 4y · up

How it ranks in Healthcare · percentile among 79 companies

Piotroski Fstronger than 16%
Net marginstronger than 9%
Return on equitystronger than 35%
Revenue growthstronger than 15%

Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets-0.127
Retained earnings / assets0.279
EBIT / assets0.053
Equity / liabilities0.345

About Amplifon S.p.A.

Amplifon S.p.A. distributes hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. The company also offers Ampli-power and Ampli-mini hearing devices. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy.

FAQ

Is AMP.MI financially healthy?

Amplifon S.p.A.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does AMP.MI pay a dividend, and is it safe?

Yes. Amplifon S.p.A. pays a dividend yielding about 2.44% with a 71.5% payout ratio, rated “stretched” for safety.

How profitable is AMP.MI?

In FY2025, Amplifon S.p.A. had a net margin of 3.8% and a return on equity of 9.1%.

Is AMP.MI overvalued or undervalued?

Amplifon S.p.A. trades at about 24.3× trailing earnings — below its 10-year norm (10-year range 32.1×–44.2×, median 40.1×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for AMP.MI?

The average Wall-Street price target for Amplifon S.p.A. is €12.84, about 27.4% above the recent price, from 16 analysts (consensus: hold).

Is AMP.MI a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Amplifon S.p.A.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone, a P/E of about 29.3×, a dividend yield of 2.44%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · IT · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.